Mirtazapine Rapid Test
Product Description
The Mirtazapine Rapid Test is a qualitative immunoassay designed for the rapid detection of mirtazapine in human urine samples. This point-of-care test provides a convenient and efficient method for screening individuals for the presence of mirtazapine, which is commonly used as an antidepressant medication. The test aids healthcare professionals in monitoring patient compliance, detecting potential misuse or abuse, and supporting therapeutic drug monitoring. The test features a simple procedure, delivering results quickly to allow for timely intervention and patient management. The ease of use makes it suitable for various settings, including clinics, hospitals, and potentially even home settings under appropriate supervision.
Features
-
Rapid results in under 10 minutes
-
Easy-to-use, visual interpretation
-
Cassette format for convenient handling
Specifications
| Parameter | Specification |
|---|---|
| Detection Target | Mirtazapine |
| Sample Type | Urine |
| Methodology | Immunochromatography |
| Detection Range | Qualitative (Positive/Negative) |
| Reaction Time | 5-10 minutes |
| Storage Conditions | 2-30°C |
| Shelf Life | 18 months |
Product Advantages
Early Screening Tool
Helps quickly identify infected individuals, implement timely isolation measures, and control the spread of the epidemic.
Suitable for Multiple Scenarios
Suitable for various scenarios such as home self-testing, corporate screening, schools, and clinics.
Reliable Quality
Strict quality control system ensures stable and reliable product performance.
Instructions for Use
- Read the instructions carefully.
- Prepare sample collection tools and the test kit.
- Collect the sample according to the instructions.
- Add the sample to the test cassette.
- Wait 15 minutes to read the results.
Certification Information
- CE Certified
- ISO13485
Interested in Mirtazapine Rapid Test?
Contact us for pricing, bulk orders, or any questions you may have.
